These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 20530411)

  • 21. Calponin h1 suppresses tumor growth of Src-induced transformed 3Y1 cells in association with a decrease in angiogenesis.
    Kaneko M; Takeoka M; Oguchi M; Koganehira Y; Murata H; Ehara T; Tozuka M; Saida T; Taniguchi S
    Jpn J Cancer Res; 2002 Aug; 93(8):935-43. PubMed ID: 12716472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine phosphorylation of calponins. Inhibition of the interaction with F-actin.
    Abouzaglou J; Bénistant C; Gimona M; Roustan C; Kassab R; Fattoum A
    Eur J Biochem; 2004 Jul; 271(13):2615-23. PubMed ID: 15206927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Live dynamics of GFP-calponin: isoform-specific modulation of the actin cytoskeleton and autoregulation by C-terminal sequences.
    Danninger C; Gimona M
    J Cell Sci; 2000 Nov; 113 Pt 21():3725-36. PubMed ID: 11034901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steric regulation of tandem calponin homology domain actin-binding affinity.
    Harris AR; Belardi B; Jreij P; Wei K; Shams H; Bausch A; Fletcher DA
    Mol Biol Cell; 2019 Dec; 30(26):3112-3122. PubMed ID: 31693446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calponin h1 induced a flattened morphology and suppressed the growth of human fibrosarcoma HT1080 cells.
    Takeoka M; Ehara T; Sagara J; Hashimoto S; Taniguchi S
    Eur J Cancer; 2002 Feb; 38(3):436-42. PubMed ID: 11818211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and purification of the h1 and h2 isoforms of calponin.
    Jin JP; Wu D; Gao J; Nigam R; Kwong S
    Protein Expr Purif; 2003 Oct; 31(2):231-9. PubMed ID: 14550641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Calponin 3 regulates actin cytoskeleton rearrangement in trophoblastic cell fusion.
    Shibukawa Y; Yamazaki N; Kumasawa K; Daimon E; Tajiri M; Okada Y; Ikawa M; Wada Y
    Mol Biol Cell; 2010 Nov; 21(22):3973-84. PubMed ID: 20861310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tail-suspended mice lacking calponin H1 experience decreased bone loss.
    Yotsumoto N; Takeoka M; Yokoyama M
    Tohoku J Exp Med; 2010 Jul; 221(3):221-7. PubMed ID: 20551601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of the Critical Site of Calponin 1 for Suppression of Ovarian Cancer Properties.
    Yamane T; Asanoma K; Kobayashi H; Liu G; Yagi H; Ohgami T; Ichinoe A; Sonoda K; Wake N; Kato K
    Anticancer Res; 2015 Nov; 35(11):5993-9. PubMed ID: 26504022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Construction of adenoviral vector encoding Calponin-1 siRNA and its effect on human myometrium cells in vitro].
    Gu Y; Zhou C; Hu L; Chen Q; Zhang W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 34(12):1231-7. PubMed ID: 20045919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A cell-free binding assay maps the LSP1 cytoskeletal binding site to the COOH-terminal 30 amino acids.
    Wong MJ; Malapitan IA; Sikorski BA; Jongstra J
    Biochim Biophys Acta; 2003 Sep; 1642(1-2):17-24. PubMed ID: 12972289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of calponin in the gene profile of metastatic cells: inhibition of metastatic cell motility by multiple calponin repeats.
    Lener T; Burgstaller G; Gimona M
    FEBS Lett; 2004 Jan; 556(1-3):221-6. PubMed ID: 14706854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of cancer phenotypes through a multifunctional actin-binding protein, calponin, that attacks cancer cells and simultaneously protects the host from invasion.
    Taniguchi S
    Cancer Sci; 2005 Nov; 96(11):738-46. PubMed ID: 16271067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of calponin 2 contributes to the quiescence of lung macrophages.
    Plazyo O; Sheng JJ; Jin JP
    Am J Physiol Cell Physiol; 2019 Oct; 317(4):C749-C761. PubMed ID: 31365293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway.
    Wang Z; Li TE; Chen M; Pan JJ; Shen KW
    Aging (Albany NY); 2020 Jan; 12(2):1867-1887. PubMed ID: 31986487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Label-free quantitative phosphorylation analysis of human transgelin2 in Jurkat T cells reveals distinct phosphorylation patterns under PKA and PKC activation conditions.
    Jang SH; Jun CD; Park ZY
    Proteome Sci; 2015; 13():14. PubMed ID: 25844069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of H1 calponin in osteoblast lineage cells leads to a decrease in bone mass by disrupting osteoblast function and promoting osteoclast formation.
    Su N; Chen M; Chen S; Li C; Xie Y; Zhu Y; Zhang Y; Zhao L; He Q; Du X; Chen D; Chen L
    J Bone Miner Res; 2013 Mar; 28(3):660-71. PubMed ID: 23044709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calponin h1-S175T point mutation enhances resistance to actin cytoskeleton perturbation in human cancer cells.
    Sugaya A; Takeoka M; Itano N; Taguchi A; Ehara T; Taniguchi S
    Anticancer Res; 2010 Apr; 30(4):1071-8. PubMed ID: 20530411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus-mediated calponin h1 gene therapy directed against peritoneal dissemination of ovarian cancer: bifunctional therapeutic effects on peritoneal cell layer and cancer cells.
    Ogura T; Kobayashi H; Ueoka Y; Okugawa K; Kato K; Hirakawa T; Hashimoto S; Taniguchi S; Wake N; Nakano H
    Clin Cancer Res; 2006 Sep; 12(17):5216-23. PubMed ID: 16951241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calponin in non-muscle cells.
    Wu KC; Jin JP
    Cell Biochem Biophys; 2008; 52(3):139-48. PubMed ID: 18946636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.